NPCENeuropace
About Neuropace
Neuropace (NASDAQ:NPCE) specializes in creating advanced neuromodulation devices aimed at improving the quality of life for patients suffering from neurological disorders, particularly epilepsy. Focused on the development and commercialization of its flagship Responsive Neurostimulation (RNS) System, the company's primary objective is to provide innovative, data-driven solutions for epilepsy management. This system is designed to monitor brain activity and deliver personalized, responsive stimulation to prevent seizures before they happen. With a commitment to advancing neurological care through technology, Neuropace is dedicated to ongoing research and development efforts to expand its product offerings and improve patient outcomes.
What is NPCE known for?
Snapshot
Public US
Ownership
1997
Year founded
171
Employees
Mountain View, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Mountain View, US
Products and/or services of Neuropace
- RNS System: A responsive neurostimulation device designed to prevent epileptic seizures by detecting abnormal brain patterns and delivering subtle electrical pulses to stabilize brain activity.
- Data Management System: Offers comprehensive data analysis tools for patient's brain activity, aiding in optimizing treatment plans and monitoring.
- Patient Data Portal: Provides patients with access to their treatment and seizure activity information, fostering engagement and self-management of their condition.
- Research and Development: Focused on advancing neurostimulation technologies and exploring new applications for their existing systems in neurological disorders.
- Professional Education: Offers training and educational resources for healthcare professionals to effectively use and implement their technology in clinical settings.
- Community Support Initiatives: Engages with patients and families through support programs and resources, enhancing the understanding and management of epilepsy.
Neuropace executive team
- Mr. Joel D. BeckerCEO, President & Director
- Dr. Martha J. Morrell M.D.Chief Medical Officer
- Ms. Rebecca L. KuhnAdvisor
- Mr. Patrick F. WilliamsChief Financial Officer
- Mr. Dylan St. JohnChief of Operations & Development
- Mr. Scott R. SchaperHead of Investor Relations
- Ms. Leah AkinGeneral Counsel & Corporate Secretary
- Ms. Katie KellerVice President of Marketing
- Mr. Chris ReeseSenior Vice President of Sales
- Ms. Amy TreadwellVice President of Human Resources